HWA
GOSS icon

HHM Wealth Advisors’s Gossamer Bio GOSS Stock Holding History

HHM Wealth Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 898
2026
Q1 		$1 Buy
+1
New +$2 ﹤0.01% 878

Other funds holding GOSS

CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
WA
Waddell & Associates Memphis, Tennessee $2.02B AUM 36.49% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
SCP
Sivia Capital Partners Mill Valley, California $822M AUM 48.82% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

HHM Wealth Advisors's GOSS Position: Q2 2026 in Review

HHM Wealth Advisors held its Gossamer Bio (GOSS) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #898.

HHM Wealth Advisors first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. 23 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • HHM Wealth Advisors held 1 share of Gossamer Bio worth $1 as of Q2 2026.
  • HHM Wealth Advisors left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #898 holding.
  • HHM Wealth Advisors first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • 23 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.